Planning for an exit starts well before the deal, and an honest look at how the different paths work can make all the difference. Join Fenwick partner Amanda Rose and Elizabeth Balta of Jade Biosciences for a fireside chat exploring the various paths to a successful biotech exit, including IPOs, reverse mergers, and M&A. Drawing on real-world experience, they’ll discuss key considerations for each strategy, how companies can position themselves for success, and practical steps to prepare for an exit in today’s market.
Whether your exit is years away or already on the horizon, the decisions you make now shape the options you’ll have later. Come with your questions, hear candid insights from two speakers with real-world experience, and stay to connect with the life science community.